A Phase Iib, Randomized, Double-Blind, Parallel-Group Study to Assess
Research payments
$606,015
Through program year 2024, $606,015 in research payments was reported against A Phase Iib, Randomized, Double-Blind, Parallel-Group Study to Assess, across 167 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $18,904 | 6 |
| 2023 | Research | $132,205 | 48 |
| 2022 | Research | $454,906 | 113 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Javier Morales Ramirez Santurce, PR Named on 22 payments
- Sara Bares Omaha, NE Named on 14 payments
- Franco Felizarta Nipomo, CA Named on 14 payments
- Moti Ramgopal Fort Lauderdale, FL Named on 11 payments
- Cynthia Firnhaber Aurora, CO Named on 10 payments
- Lizette Santiago Colon San Juan, PR Named on 10 payments
- David Morris Palm Springs, CA Named on 8 payments
- Blair Thedinger Kansas City, MO Named on 7 payments
- Michael Wohlfeiler Miami Beach, FL Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.